For the year ending 2025-12-31, EBS made $742,900K in revenue. $52,600K in net income. Net profit margin of 7.08%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Total revenues | 742,900 | 1,043,600 | ||
| Cost of product and services sales, net | 326,200 | 185,900 | ||
| Research and development | 53,200 | 70,700 | ||
| Selling, general and administrative | 186,100 | 616,000 | ||
| Amortization of intangible assets | 65,100 | 65,100 | ||
| Goodwill impairment | 0 | - | ||
| Impairment of long-lived assets | 12,200 | 163,200 | ||
| Total operating expenses | 642,800 | 1,152,300 | ||
| Income (loss) from operations | 100,100 | -108,700 | ||
| Interest expense | 59,300 | 71,000 | ||
| Gain on sale of business | 0 | 24,300 | ||
| Gain (loss) on extinguishments of debt | -12,200 | - | ||
| Other, net | 54,200 | 12,500 | ||
| Total other income (expense), net | -17,300 | -34,200 | ||
| Income (loss) before income taxes | 82,800 | -142,900 | ||
| Income tax provision | 30,200 | 47,700 | ||
| Net income (loss) | 52,600 | -190,600 | ||
| Basic EPS | 0.98 | -3.6 | ||
| Diluted EPS | 0.93 | -3.6 | ||
| Basic Average Shares | 53,500,000 | 53,000,000 | ||
| Diluted Average Shares | 56,700,000 | 53,000,000 | ||
Emergent BioSolutions Inc. (EBS)
Emergent BioSolutions Inc. (EBS)